16 results
Community Acquired Pneumonia - Inpatient and Outpatient Treatment Regimens
 • Outpatient, no significant comorbidities
 • Outpatient,
Community Acquired ... Pneumonia - Inpatient ... and Outpatient Treatment ... EricsMedicalLectures/ #CAP ... #management #pulmonary
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Unknown • 6-7 cases ... - Clinical manifestations ... DDX: • CAP, ... Treatment: • ... #COP #BOOP #pulmonary
Salicylate Toxicity - Diagnosis and Management

Consider if:
1) Patient is hot and altered
2) You see tachypnea with
no respiratory cause ... 3) Labs show anion-gap ... , Diaphoresis, Pulmonary ... , Shock Labs: Anion-Gap ... diagnosis #management #Treatment
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Pneumonia (CAP) ... Obtain in severe CAP ... Pseudomonas) • Severe CAP ... #CAP #Diagnosis ... #Pulmonary #Community
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
• Most common cause ... : Aspiration pneumonia ... Lung Abscess - Clinical ... #pulmonary #differential ... #causes #management
Blastomycosis (Blastomyces): Gilchrist’s disease, Chicago disease - Summary Sheet
 • Morphology
 • Geography, Reservoir and Mode
- Sporadic cases ... inoculation • Clinical ... - Acute pulmonary ... blastomycosis – resembles community-acquired ... pneumonia with
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
lung disease Caused ... shunt (Type 2) Clinical ... echocardiography - Assess ... Can also be seen ... ) on room air Treatment
1. In this randomized controlled trial, oral lefamulin was noninferior to oral moxifloxacin for treating community-acquired
moxifloxacin for treating community-acquired ... pneumonia, with ... regards to early clinical ... more diarrhea and nausea ... #CAP ©2019 2
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... without other cause ... elevated BNP, high CVP ... , and CXR with pulmonary ... hematology #diagnosis #comparison
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
Cryptogenic Organizing Pneumonia ... misdiagnosed as CAP ... DIAGNOSTICS: Clinical ... , neoplastic) TREATMENT ... diagnosis #management #pulmonary